Multiplex Assay Kit for Thrombospondin 1 (THBS1) ,etc. by FLIA (Flow Luminescence Immunoassay)

TSP1; Thrombospondin-1p180

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Thrombospondin 1 (THBS1) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Thrombospondin 1 (THBS1) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Thrombospondin 1 (THBS1) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Thrombospondin 1 (THBS1) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 78-99 95
EDTA plasma(n=5) 99-105 102
heparin plasma(n=5) 86-101 93
sodium citrate plasma(n=5) 82-102 92

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Thrombospondin 1 (THBS1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Thrombospondin 1 (THBS1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Thrombospondin 1 (THBS1) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 79-88% 80-105% 97-104% 94-102%
EDTA plasma(n=5) 89-104% 87-98% 96-103% 90-99%
heparin plasma(n=5) 80-88% 83-95% 87-102% 81-105%
sodium citrate plasma(n=5) 90-99% 78-99% 89-98% 93-102%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:THBS1) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Journal of Physiology and Biochemistry Glucose and insulin modify thrombospondin 1 expression and secretion in primary adipocytes from diet-induced obese rats SpringerLink: 1v552w21p7423764
Basic Research in Cardiology Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation PubMed: 22899170
PloS one Anthocyanin-Rich Purple Corn Extract Inhibit Diabetes-Associated Glomerular Angiogenesis Pubmed: 24278186
BMC Complementary and Alternative Medicine Identification of plasma protein markers common to patients with malignant tumour and Abnormal Savda in Uighur medicine: a prospective clinical study Pubmed:25652121
Oncotarget Novel circulating peptide biomarkers for esophageal squamous cell carcinoma revealed by a magnetic bead-based MALDI-TOFMS assay pubmed:26993605
Osteoarthritis and Cartilage Orosomucoid 2 serves for predicting but not for monitoring drug response in patients with knee osteoarthritis treated with chondroitin sulfate/glucosamine … 10.1016:j.joca.2018.02.412
GEBURTSHILFE UND FRAUENHEILKUNDE Prediction of Spontaneous Preterm Birth in At-risk Women Using Thrombospondin 1 from Cervicovaginal Fluid: A Prospective Observational Study 34531612
NPJ Regen Med Mesenchymal stromal cells mitigate liver damage after extended resection in the pig by modulating thrombospondin-1/TGF-β 34862411
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA611Hu01 Recombinant Thrombospondin 1 (THBS1) Positive Control; Immunogen; SDS-PAGE; WB.
RPA611Hu02 Recombinant Thrombospondin 1 (THBS1) Positive Control; Immunogen; SDS-PAGE; WB.
PAA611Hu02 Polyclonal Antibody to Thrombospondin 1 (THBS1) WB; IHC; ICC; IP.
PAA611Hu01 Polyclonal Antibody to Thrombospondin 1 (THBS1) WB; IHC; ICC; IP.
LAA611Hu71 Biotin-Linked Polyclonal Antibody to Thrombospondin 1 (THBS1) WB; IHC; ICC.
MAA611Hu22 Monoclonal Antibody to Thrombospondin 1 (THBS1) WB; IHC; ICC; IP.
SEA611Hu ELISA Kit for Thrombospondin 1 (THBS1) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA611Hu Multiplex Assay Kit for Thrombospondin 1 (THBS1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.